DEBT (Tables)

3 Months Ended

Dec. 31, 2025

Debt Disclosure [Abstract]

Schedule of Long-Term Debt and Effective Interest Rates

Our indebtedness as of December 31, 2025 and September 30, 2025 is detailed in the table below. Refer below for discussion of the revolving credit facility.

	December 31, 2025		September 30, 2025
Seller Note – Bolder BioPath (Related party)	$	94	$	150
Seller Payable - Orient BioResource Center	3,235		3,235
Second Lien Notes	24,694		23,220
Convertible Senior Notes	118,168		116,440
Term Loan Facility, DDTL and Incremental Term Loans	267,395		268,654
Total debt before unamortized debt issuance costs	$	413,586	$	411,699
Less: Debt issuance costs not amortized	(7,813)		(9,576)
Total debt, net of unamortized debt issuance costs	$	405,773	$	402,123
Less: Current portion	(405,773)		(402,123)
Total Long-term debt	$	—	$	—

Below are the weighted-average effective interest rates for the loans available under the Credit Agreement:

	Three Months Ended December 31,
	2025		2024
Effective interest rates:
Term Loan	11.57	%	11.71	%
Initial DDTL	11.56	%	11.69	%
Additional DDTL	11.62	%	11.82	%